STOCK TITAN

ANI Pharmaceuticals director proposes $386K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

ANI Pharmaceuticals Inc. (ANIP) director and officer Nikhil Lalwani filed a notice covering a proposed sale of 5,400 common shares, with an aggregate market value of $385,776.00 and an approximate sale date of November 16, 2026. The shares were acquired from the issuer as restricted stock awards on March 7, 2026. The notice lists three prior 5,400-share sales on August 25, September 15 and October 15, reported as 10b5-1 sales; the plan adoption date was May 26, 2026.

Proposed shares for sale 5,400 shares Common shares; approximate sale date November 16, 2026
Aggregate market value $385,776.00 Shares covered by the proposed sale
Shares outstanding 22,718,931 shares Number listed in the Form 144
Gross proceeds $401,216.22 5,400 shares sold August 25, 2026
Gross proceeds $383,400.00 5,400 shares sold September 15, 2026
Gross proceeds $388,192.50 5,400 shares sold October 15, 2026
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Restricted Stock Awards financial
"Nature of Acquisition Transaction: Restricted Stock Awards"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ANIP shares did Nikhil Lalwani report for sale?

The notice lists a proposed sale of 5,400 ANI Pharmaceuticals common shares by director and officer Nikhil Lalwani, with an aggregate market value of $385,776.00 and an approximate sale date of November 16, 2026.

What earlier ANIP sales by Nikhil Lalwani are listed?

The notice lists 5,400 shares sold on August 25, 2026, for gross proceeds of $401,216.22; 5,400 on September 15 for $383,400.00; and 5,400 on October 15 for $388,192.50. Each is identified as a 10b5-1 sale, and the plan adoption date is May 26, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading